DASH™ Rapid PCR System Characteristics:
Central lab quality, quantitative PCR results
Designed to be multiplex-capable in a single cartridge*
Time to Result
Quantitative PCR and reverse transcription, real-time PCR (RT-qPCR)
Easy to Use
Intuitive user interface with only 1 minute of actual hands on time
Paramagnetic particle purification
Built to run a wide variety of sample types*
Positive, negative or invalid
DASH™ is a sample-to-answer quantitative PCR system that is designed to automatically identify viral and bacterial agents in only 15 minutes. During the first 10 minutes, samples are extracted and purified with sequence-specific capture probes. Paramagnetic particles (PMP) bind the target probe complex. Targets are then separated magnetically from the swab extraction buffer, washed and transported to the PCR chamber. During the last 5 minutes of the assay, 40 PCR temperature cycles are performed. During the 40 cycles, fluorescence is measured with a four-channel optical system.
DASH™ Rapid PCR System:
The DASH™ Rapid PCR System is a point of care (POC) in vitro diagnostic (IVD) device that is designed to detect nucleic acids of target pathogens from various sample types. The system consists of an electromechanical instrument, barcode scanner and test cartridges.
The DASH™ Cartridge contains all reagents necessary to perform a test and is built to be multiplex-capable.* DASH™ Cartridges use stabilized reagents for storage at room temperature.
The DASH™ Rapid PCR System delivers central lab quality results at the point of care, is simple and easy to use, and can be operated with minimal training.
through all the steps, making it just
as easy to use as a coffee maker.
Chad Achenbach, M.D.
Associate Director of Infectious Diseases at Feinberg School of Medicine,
Northwestern University, Chicago, IL.
Fierce BioTech – 10/3/22
Step 1. Scan
Step 2. Add
Step 3. Load
Step 4. Report
Clinical research results from a recently published
Concordant results for 307 tests1
to Cepheid GeneXpert
“DASH POC SARS-CoV-2 PCR was accurate, easy to use, and provided fast results (approximately 15 minutes) in real-life clinical settings with an overall performance similar to a EUA-approved laboratory-based PCR.”
The DASH SARS-CoV-2/S Test is a real-time RT-PCR assay intended for the qualitative detection of RNA from SARS-CoV-2 in direct anterior nasal swab specimens from individuals suspected of COVID-19 by their healthcare provider. Positive results are indicative of the presence of SARS-CoV-2 RNA; clinical correlation with patient history and other diagnostic information is necessary to determine patient infection status. Positive results do not rule out bacterial infection or co-infection with other viruses. The agent detected may not be the definite cause of disease.
*This product has not been FDA cleared or approved. It has been authorized for emergency use by FDA under an EUA for use by authorized laboratories. Additional indications beyond SARS-CoV-2 will require separate FDA clearances, and are not commercially available at this time.
This product has been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens.
The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(bx1) of the Federal Food, Drug and Cosmetic Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated, or authorization is revoked sooner.